Apollo Hospitals Enterprise Ltd Stock Price Today (NSE: APOLLOHOSP)
Fundamental Score
Apollo Hospitals Enterprise Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Apollo Hospitals Enterprise Ltd share price today is ₹7608.50, up +0.00% on NSE/BSE as of 20 February 2026. Apollo Hospitals Enterprise Ltd (APOLLOHOSP) is a Large-cap company in the Hospital sector with a market capitalisation of ₹1.05L (Cr). The 52-week high for APOLLOHOSP share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 62.70x, APOLLOHOSP is currently trading above its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 18.42% and a debt-to-equity ratio of 0.88.
Apollo Hospitals Enterprise Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Apollo Hospitals Enterprise Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Apollo Hospitals Share Price: A Conservative Investor's Perspective
Within the healthcare sector, hospitals are facing increasing pressure to deliver value-based care while navigating complex regulatory landscapes. This analysis examines Apollo Hospitals Enterprise Ltd. (Apollo Hospitals share price: ₹7152.5) from the viewpoint of a conservative value investor primarily concerned with capital safety. We will examine key financial metrics and compare Apollo to its peers. This is a segment of a larger 80-parameter fundamental audit, personally verified by Sweta Mishra.
Apollo Hospitals trades at a Price-to-Earnings (PE) ratio of 62.7. This is a seemingly high valuation, demanding a careful assessment of the company's future earnings potential and growth prospects. A crucial question to ask: is the high PE justified? The sector peers, including
Nephro Care India Limited, offer a different picture in terms of management quality and operational efficiency. A comparative analysis of leadership effectiveness is essential when evaluating investments in healthcare companies, particularly when deciding if a higher premium is warranted.The Return on Capital Employed (ROCE) for Apollo Hospitals stands at 16.64%. This is an important measure of how effectively the company is using its capital to generate profits. A consistent and healthy ROCE, like Apollo's, suggests a degree of competitive advantage or "moat." However, it's crucial to understand the sources of this advantage. Does it stem from brand recognition, network effects, specialized services, or cost efficiencies? A deep dive into the company's operational strengths is necessary to determine the sustainability of this moat in the face of evolving market dynamics and increasing competition.
While a 16.64% ROCE is respectable, a conservative investor would need to critically evaluate if this level of return is sufficient to justify the current Apollo Hospitals share price, especially given the relatively high PE ratio. Further investigation into the company's debt levels, cash flow generation, and future capital expenditure plans is essential before making any investment decision. This analysis aims to provide a framework for further due diligence and should not be construed as investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Apollo Hospitals Enterprise Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of APOLLOHOSP across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (18.42%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (16.64%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Robust Profit Growth (25.98%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (14.15% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (32.84% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (33.72% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (6.22x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹3504.80 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 65.32%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Risk Factors
2 factors identified
Premium Valuation Risk (P/E: 62.70x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Low Promoter Commitment (28.02%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
Apollo Hospitals Enterprise Ltd Financial Statements
Comprehensive financial data for Apollo Hospitals Enterprise Ltd including income statement, balance sheet and cash flow
About APOLLOHOSP (Apollo Hospitals Enterprise Ltd)
Apollo Hospitals Enterprise Ltd (APOLLOHOSP) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a current market capitalisation of ₹1.05L (Cr). Apollo Hospitals Enterprise Ltd has delivered a Return on Equity (ROE) of 18.42% and a ROCE of 16.64%. The debt-to-equity ratio stands at 0.88, reflecting the company's capital structure. Investors tracking APOLLOHOSP share price can monitor key metrics including P/E ratio, promoter holding of 28.02%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
Latest News
APOLLOHOSP Share Price: Frequently Asked Questions
What is the current share price of Apollo Hospitals Enterprise Ltd (APOLLOHOSP)?
As of 20 Feb 2026, 06:09 am IST, Apollo Hospitals Enterprise Ltd share price is ₹7608.50. The APOLLOHOSP stock has a market capitalisation of ₹1.05L (Cr) on NSE/BSE.
Is APOLLOHOSP share price Overvalued or Undervalued?
APOLLOHOSP share price is currently trading at a P/E ratio of 62.70x, compared to the industry average of 52.84x. Based on this relative valuation, the Apollo Hospitals Enterprise Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of APOLLOHOSP share price?
The 52-week high of APOLLOHOSP share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Apollo Hospitals Enterprise Ltd share price?
Key factors influencing APOLLOHOSP share price include quarterly earnings growth (Sales Growth: 12.78%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Apollo Hospitals Enterprise Ltd a good stock for long-term investment?
Apollo Hospitals Enterprise Ltd shows a 5-year Profit Growth of 33.72% and an ROE of 18.42%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.88 before investing in APOLLOHOSP shares.
How does Apollo Hospitals Enterprise Ltd compare with its industry peers?
Apollo Hospitals Enterprise Ltd competes with major peers in the Hospital. Investors should compare APOLLOHOSP share price P/E of 62.70x and ROE of 18.42% against the industry averages to determine competitive standing.
What is the P/E ratio of APOLLOHOSP and what does it mean?
APOLLOHOSP share price has a P/E ratio of 62.70x compared to the industry average of 52.84x. Investors pay ₹63 for every ₹1 of annual earnings.
How is APOLLOHOSP performing according to Bull Run's analysis?
APOLLOHOSP has a Bull Run fundamental score of 50.2/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does APOLLOHOSP belong to?
APOLLOHOSP operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Apollo Hospitals Enterprise Ltd share price.
What is Return on Equity (ROE) and why is it important for APOLLOHOSP?
APOLLOHOSP has an ROE of 18.42%, which indicates excellent management efficiency. ROE measures how efficiently Apollo Hospitals Enterprise Ltd generates profits from shareholders capital.
How is APOLLOHOSP debt-to-equity ratio and what does it indicate?
APOLLOHOSP has a debt-to-equity ratio of 0.88, which indicates moderate leverage that should be monitored.
What is APOLLOHOSP dividend yield and is it a good dividend stock?
APOLLOHOSP offers a dividend yield of 0.26%, meaning you receive ₹0.26 annual dividend for every ₹100 invested in Apollo Hospitals Enterprise Ltd shares.
How has APOLLOHOSP share price grown over the past 5 years?
APOLLOHOSP has achieved 5-year growth rates of: Sales Growth 14.15%, Profit Growth 33.72%, and EPS Growth 32.84%.
What is the promoter holding in APOLLOHOSP and why does it matter?
Promoters hold 28.02% of APOLLOHOSP shares, with 8.58% pledged. High promoter holding often indicates strong management confidence in Apollo Hospitals Enterprise Ltd.
What is APOLLOHOSP market capitalisation category?
APOLLOHOSP has a market capitalisation of ₹104826 crores, placing it in the Large-cap category.
How volatile is APOLLOHOSP stock?
APOLLOHOSP has a beta of N/A. A beta > 1 suggests the Apollo Hospitals Enterprise Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is APOLLOHOSP operating profit margin trend?
APOLLOHOSP has a 5-year average Operating Profit Margin (OPM) of 13.09%, indicating the company's operational efficiency.
How is APOLLOHOSP quarterly performance?
Recent quarterly performance shows Apollo Hospitals Enterprise Ltd YoY Sales Growth of 12.78% and YoY Profit Growth of 25.98%.
What is the institutional holding pattern in APOLLOHOSP?
APOLLOHOSP has FII holding of 44.20% and DII holding of 21.12%. Significant institutional holding often suggests professional confidence in the Apollo Hospitals Enterprise Ltd stock.